mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
5e-07 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
1e-06 |
mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
2e-06 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
3e-06 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-06 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
-0.22 |
3e-06 |
mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
3e-06 |
mRNA |
AZD7762 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
7e-06 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
8e-06 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |